<DOC>
	<DOCNO>NCT02174367</DOCNO>
	<brief_summary>â€¢ Main objectives outcome measure . 1 . Establish prevalence factor contribute fatty liver disease liver fibrosis patient psoriasis . Fatty liver disease diagnose via ultrasound . Liver fibrosis diagnose liver biopsy non-invasive test fibrosis include transient elastography , ultrasound , serum marker fibrosis include procollagen-3-N-terminal peptide ( P3NP ) . 2 . Evaluate non-invasive marker liver fibrosis psoriasis population . Namely transient elastography , standard liver function test P3NP . 3 . Evaluate impact psoriasis disease severity comorbidities include metabolic syndrome response treatment patient psoriasis . Data co-morbid disease collect questionnaire review medical record . Response treatment assess use psoriasis area severity index ( PASI ) physician global assessment ( PGA ) dermatology life quality index ( DLQI ) . - Study population : 380 patient moderate severe psoriasis prospectively recruit study . - Chief investigator : Professor Jonathan Barker . Co-investigator : Professor Catherine Smith - Sponsor/funding organization : Pfizer Biomedical Research Centre ( BRC ) Guys St Thomas Hospitals Trust</brief_summary>
	<brief_title>An Observational Cohort Study Evaluating Fatty Liver Disease Liver Fibrosis Moderate Severe Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Patients give write informed consent Psoriasis patient chronic plaquetype psoriasis ; PASI 10 currently past . 18 yr . age Patients give write informed consent Patients 18 yr . age Patients PASI le 10 . Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Chronic plaque psoriasis</keyword>
	<keyword>Liver fibrosis</keyword>
	<keyword>Fatty liver disease</keyword>
	<keyword>Non-alcoholic fatty liver disease</keyword>
	<keyword>Transient elastography</keyword>
	<keyword>Fibroscan</keyword>
	<keyword>Procollagen-3 N-Terminal peptide</keyword>
	<keyword>Alanine aminotransferase</keyword>
	<keyword>Liver function test</keyword>
</DOC>